MTT FORMAZAN
Modify Date: 2024-01-02 15:41:28
MTT FORMAZAN structure
|
Common Name | MTT FORMAZAN | ||
|---|---|---|---|---|
| CAS Number | 57360-69-7 | Molecular Weight | 335.42600 | |
| Density | 1.22g/cm3 | Boiling Point | 493.1ºC at 760 mmHg | |
| Molecular Formula | C18H17N5S | Melting Point | N/A | |
| MSDS | USA | Flash Point | 252ºC | |
| Name | 4,5-Dimethyl-2-{(E)-[(E)-phenyl(phenylhydrazono)methyl]diazenyl}- 1,3-thiazole |
|---|---|
| Synonym | More Synonyms |
| Density | 1.22g/cm3 |
|---|---|
| Boiling Point | 493.1ºC at 760 mmHg |
| Molecular Formula | C18H17N5S |
| Molecular Weight | 335.42600 |
| Flash Point | 252ºC |
| Exact Mass | 335.12000 |
| PSA | 90.24000 |
| LogP | 5.39050 |
| Index of Refraction | 1.657 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | S22-24/25 |
| RIDADR | NONH for all modes of transport |
|
β-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A.
PLoS ONE 9(11) , e112818, (2014) Alzheimer's disease (AD) is characterized by progressive dysfunction of memory and higher cognitive functions with abnormal accumulation of extracellular amyloid plaques and intracellular neurofibrill... |
|
|
Mechanism of Dose-Dependent Regulation of UBE1L by Polyphenols in Human Bronchial Epithelial Cells.
J. Cell. Biochem. 116 , 1553-62, (2015) Ubiquitin activating enzyme E1-like (UBE1L) is the activating enzyme for ISG15ylation (ISG15, interferon stimulated gene 15). UBE1L is thought to be a candidate tumor suppressor gene and has positive ... |
|
|
Activated Schwann Cell-Like Cells on Aligned Fibrin-Poly(Lactic-Co-Glycolic Acid) Structures: A Novel Construct for Application in Peripheral Nerve Regeneration.
Cells Tissues Organs 200 , 287-99, (2015) Tissue engineering approaches in nerve regeneration search for ways to support gold standard therapy (autologous nerve grafts) and to improve results by bridging nerve defects with different kinds of ... |
| MFCD00080731 |